Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.99% | 5.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.99% | 5.57% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.99% | 5.57% | |||
| SG&A Expenses | 26.83% | 2.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 38.11% | 15.72% | |||
| Operating Income | -39.30% | -16.08% | |||
| Income Before Tax | -32.83% | -25.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.83% | -25.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.83% | -25.07% | |||
| EBIT | -39.30% | -16.08% | |||
| EBITDA | -39.14% | -16.08% | |||
| EPS Basic | 93.15% | -18.62% | |||
| Normalized Basic EPS | 91.21% | -18.40% | |||
| EPS Diluted | 93.15% | -18.62% | |||
| Normalized Diluted EPS | 91.21% | -18.40% | |||
| Average Basic Shares Outstanding | 1,411.70% | 5.64% | |||
| Average Diluted Shares Outstanding | 1,411.70% | 5.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||